85 related articles for article (PubMed ID: 18181172)
1. Ets-1 triggers and orchestrates the malignant phenotype of mammary cancer cells within their matrix environment.
Furlan A; Vercamer C; Desbiens X; Pourtier A
J Cell Physiol; 2008 Jun; 215(3):782-93. PubMed ID: 18181172
[TBL] [Abstract][Full Text] [Related]
2. Hepatocyte growth factor in invasive growth of carcinomas.
Desiderio MA
Cell Mol Life Sci; 2007 Jun; 64(11):1341-54. PubMed ID: 17415522
[TBL] [Abstract][Full Text] [Related]
3. Aged Breast Extracellular Matrix Drives Mammary Epithelial Cells to an Invasive and Cancer-Like Phenotype.
Bahcecioglu G; Yue X; Howe E; Guldner I; Stack MS; Nakshatri H; Zhang S; Zorlutuna P
Adv Sci (Weinh); 2021 Nov; 8(22):e2100128. PubMed ID: 34617419
[TBL] [Abstract][Full Text] [Related]
4. Adhesion and Migration Response to Radiation Therapy of Mammary Epithelial and Adenocarcinoma Cells Interacting with Different Stiffness Substrates.
Panzetta V; Verde G; Pugliese M; Artiola V; Arrichiello C; Muto P; Commara M; Netti PA; Fusco S
Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32384675
[TBL] [Abstract][Full Text] [Related]
5. Evolution of cell motility in an individual-based model of tumour growth.
Gerlee P; Anderson AR
J Theor Biol; 2009 Jul; 259(1):67-83. PubMed ID: 19285513
[TBL] [Abstract][Full Text] [Related]
6. Microenvironmental independence associated with tumor progression.
Anderson AR; Hassanein M; Branch KM; Lu J; Lobdell NA; Maier J; Basanta D; Weidow B; Narasanna A; Arteaga CL; Reynolds AB; Quaranta V; Estrada L; Weaver AM
Cancer Res; 2009 Nov; 69(22):8797-806. PubMed ID: 19887618
[TBL] [Abstract][Full Text] [Related]
7. Cell swelling, softening and invasion in a three-dimensional breast cancer model.
Han YL; Pegoraro AF; Li H; Li K; Yuan Y; Xu G; Gu Z; Sun J; Hao Y; Gupta SK; Li Y; Tang W; Tang X; Teng L; Fredberg JJ; Guo M
Nat Phys; 2020 Jan; 16(1):101-108. PubMed ID: 32905405
[TBL] [Abstract][Full Text] [Related]
8. Exploring Salivary Epithelial Dysfunction in Sjögren's Disease.
Noll B; Beckman M; Bahrani Mougeot F; Mougeot JL
Int J Mol Sci; 2024 May; 25(9):. PubMed ID: 38732189
[TBL] [Abstract][Full Text] [Related]
9. Nuclear import of PTPN18 inhibits breast cancer metastasis mediated by MVP and importin β2.
Wang T; Ba X; Zhang X; Zhang N; Wang G; Bai B; Li T; Zhao J; Zhao Y; Yu Y; Wang B
Cell Death Dis; 2022 Aug; 13(8):720. PubMed ID: 35982039
[TBL] [Abstract][Full Text] [Related]
10. Pillars and Gaps of S-Nitrosylation-Dependent Epigenetic Regulation in Physiology and Cancer.
Salvatori L; Spallotta F; Gaetano C; Illi B
Life (Basel); 2021 Dec; 11(12):. PubMed ID: 34947954
[TBL] [Abstract][Full Text] [Related]
11. MiR-145: a potential biomarker of cancer migration and invasion.
Xu WX; Liu Z; Deng F; Wang DD; Li XW; Tian T; Zhang J; Tang JH
Am J Transl Res; 2019; 11(11):6739-6753. PubMed ID: 31814885
[TBL] [Abstract][Full Text] [Related]
12. Ets-1 drives breast cancer cell angiogenic potential and interactions between breast cancer and endothelial cells.
Furlan A; Vercamer C; Heliot L; Wernert N; Desbiens X; Pourtier A
Int J Oncol; 2019 Jan; 54(1):29-40. PubMed ID: 30365153
[TBL] [Abstract][Full Text] [Related]
13. TGFβ1 regulates HGF-induced cell migration and hepatocyte growth factor receptor MET expression via C-ets-1 and miR-128-3p in basal-like breast cancer.
Breunig C; Erdem N; Bott A; Greiwe JF; Reinz E; Bernhardt S; Giacomelli C; Wachter A; Kanthelhardt EJ; Beißbarth T; Vetter M; Wiemann S
Mol Oncol; 2018 Sep; 12(9):1447-1463. PubMed ID: 30004628
[TBL] [Abstract][Full Text] [Related]
14. ESE-1/ELF3 mRNA expression associates with poor survival outcomes in HER2
Kar A; Gutierrez-Hartmann A
Oncotarget; 2017 Sep; 8(41):69622-69640. PubMed ID: 29050229
[TBL] [Abstract][Full Text] [Related]
15. The Influence of Biomaterials on Cytokine Production in 3D Cultures.
Regier MC; Montanez-Sauri SI; Schwartz MP; Murphy WL; Beebe DJ; Sung KE
Biomacromolecules; 2017 Mar; 18(3):709-718. PubMed ID: 28157290
[TBL] [Abstract][Full Text] [Related]
16. Multiple roles of CD90 in cancer.
Kumar A; Bhanja A; Bhattacharyya J; Jaganathan BG
Tumour Biol; 2016 Sep; 37(9):11611-11622. PubMed ID: 27337957
[TBL] [Abstract][Full Text] [Related]
17. Implications of miR cluster 143/145 as universal anti-oncomiRs and their dysregulation during tumorigenesis.
Das AV; Pillai RM
Cancer Cell Int; 2015; 15():92. PubMed ID: 26425114
[TBL] [Abstract][Full Text] [Related]
18. The breast cancer oncogene EMSY represses transcription of antimetastatic microRNA miR-31.
Viré E; Curtis C; Davalos V; Git A; Robson S; Villanueva A; Vidal A; Barbieri I; Aparicio S; Esteller M; Caldas C; Kouzarides T
Mol Cell; 2014 Mar; 53(5):806-18. PubMed ID: 24582497
[TBL] [Abstract][Full Text] [Related]
19. Senescent fibroblasts enhance early skin carcinogenic events via a paracrine MMP-PAR-1 axis.
Malaquin N; Vercamer C; Bouali F; Martien S; Deruy E; Wernert N; Chwastyniak M; Pinet F; Abbadie C; Pourtier A
PLoS One; 2013; 8(5):e63607. PubMed ID: 23675494
[TBL] [Abstract][Full Text] [Related]
20. Ets-1 is a transcriptional mediator of oncogenic nitric oxide signaling in estrogen receptor-negative breast cancer.
Switzer CH; Cheng RY; Ridnour LA; Glynn SA; Ambs S; Wink DA
Breast Cancer Res; 2012 Sep; 14(5):R125. PubMed ID: 22971289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
